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The middle ear refers to an air-filled space between the tympanic membrane and the
oval window. It is connected to the nasopharynx by the eustachian tube and is in close
proximity to the temporal lobe, cerebellum, jugular bulb, and the labyrinth of the inner
ear. The middle ear contains three ossicles—the malleus, incus and stapes—which
are responsible for transmission of sound vibration from the eardrum to the cochlea.
This air-filled cavity is traversed by the facial nerve before it exits the skull via the sty-
lomastoid foramen.1,2 The facial nerve provides motor innervation to the muscles of
facial expression.
COMMON MIDDLE EAR SURGERIES
Middle ear disease affects patients of all ages. Common middle ear pathologic condi-
tions requiring surgery in adults include tympanoplasty (reconstructive surgery for the
tympanic membrane, or eardrum), stapedectomy or ossiculoplasty for otosclerosis,
mastoidectomy for removal of infected air cells within the mastoid bone, and removal
of cholesteoma.2 Common middle ear surgery in children includes tympanoplasty,
mastoidectomy, myringotomy, grommet insertion. and cochlear implantation.2
Some of these procedures can be performed under local anesthesia, although obvi-
ously, all surgery can be performed under general anesthesia if necessitated by
patient or surgical factors (Box 1).
ANESTHETIC CONSIDERATIONS IN MIDDLE EAR SURGERY
Given the unique location, size, and delicate content of the middle ear, great care must
be taken during the perioperative period. Special considerations include: provision ofU
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Common procedures in middle ear surgery
Local anesthesia
Surgical factors







 Cholesteoma surgery via intact ear canal (IOFNM)
Patient factors
 Adult





 Complicated surgery (eg, extensive scar tissue in middle ear)
Patient factors
 Children
 Mentally unstable, uncooperative patients
 Patients who request general anesthesia

























































Ra bloodless surgical field, attention to patient’s head positioning, airway management,
facial nerve monitoring, the effect of nitrous oxide on the middle ear, a smooth and
calm recovery, and prevention of postoperative nausea and vomiting (PONV).2–5
A bloodless surgical field is ideal, as even small amounts of blood will obscure the
surgeon’s view in microsurgery. A combination of physical and pharmacologic tech-
niques is used to minimize bleeding. Attention to patient’s head positioning is impor-
tant to avoid venous obstruction and congestion. In addition, extreme hyperextension
or torsion can cause injury to the brachial plexus and the cervical spine.4 In patients
with carotid atherosclerosis, carotid blood flow may be compromised or plaque
emboli dislodged, and it is worth auscultating for carotid bruit before surgery. During
general anesthesia, the airway can be maintained with a laryngeal mask airway (LMA)
or endotracheal intubation; intubation may bemore appropriate if extreme neck exten-
sion or rotation is required. LMA, however, is a suitable alternative for most middle ear
surgery, and a wide range of devices are now available. A well-documented potential
complication of otologic surgery is facial nerve paralysis, and a nerve stimulator is
often employed for intraoperative monitoring of evoked facial nerve electromyo-
graphic activity to aid preservation of the facial nerve. Muscle relaxants should beXATC208_proof ■ 20 July 2010 ■ 10:24 pm
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avoided in this circumstance or, if neuromuscular block is needed to facilitate smooth
intubation, choose a dose and an agent (eg, mivacurium no longer manufactured in the
United States) that ensures the return of function before the need for neuromuscular
monitoring arises.3–5 It also should be borne in mind that sudden unexpected patient
movement may jeopardize the success of surgery, and depth of anesthesia monitoring
may be useful. The use of nitrous oxide in middle ear surgery is controversial. A
smooth recovery without coughing or straining is important, especially in patients
who have undergone reconstructive middle ear surgery to prevent prosthesis
displacement. PONV is a common problem after middle ear surgery that can be mini-
mized by appropriate choice of anesthetic technique and antiemetic prophylaxis.3–5
Most middle ear procedures can be performed as outpatient surgery; thus rapid
recovery, good analgesia, and avoidance of nausea and vomiting are essential.6
PREOPERATIVE ASSESSMENT
For adults, simple middle ear surgery can be performed under local or general anes-
thesia, although complicated or long procedures should be performed under general
anesthesia. Patients who are able to understand the procedure, and to communicate
and cooperate throughout the procedure, are suitable candidates for local anesthesia
with or for foregoing sedation.7 Patients undergoing middle ear surgery often suffer
from extensive hearing loss, thus hindering their ability to cooperate, and in this situ-
ation, surgery might be better performed under general anesthesia. Leaving the
hearing aid in situ in the nonsurgical ear before induction and replacement before
emergence may help to minimize anxiety and ease communication. Oral anxiolysis
premedication with benzodiazepines can be considered or standard sedation regi-
mens used intraoperatively. A history of cardiovascular disease, hypovolemia, and
anemia will limit the degree of hypotension possible. In pediatric patients, in addition
to the usual components of preoperative assessment, it is important to check for
coexisting syndromes and recent upper respiratory tract infection.6
CHOICE OF ANESTHESIA
Four nerves provide innervation to the ear. The auriculotemporal nerve supplies the
outer auditory meatus; the great auricular nerve supplies the medial and lower aspect
of the auricle and part of the external auditory meatus. The auricular branch of the
vagus nerve supplies the concha and the external auditory meatus, and the tympanic
nerves supply the tympanic cavity.1,4
General or local anesthesia has advantages and disadvantages. Uncomplicated
middle ear surgery can be performed under local anesthesia. In a study on local anes-
thesia in middle ear surgery by Caner and colleagues,8 patients were premedicated
with meperidine and atropine intramuscularly 30 minutes before being taken to
surgery, and 5 mg to 10 mg diazepam was given intravenously if the patient was still
agitated in the operating room. Two percent lidocaine with 1:10,000 epinephrine was
used for infiltration and auriculotemporal/auricular nerve blocks. Seventy-three of the
100 patients said they would prefer local anesthesia for a similar operation in the
future. In a similar survey, Yung7 found the most common discomforts reported
were noise during surgery and anxiety, followed by dizziness, backache, claustro-
phobia, and earache. Despite these discomforts, however, 89% of patients said
they would prefer local anesthesia for similar operations in the future. Pain was felt
mainly at the beginning of surgery when multiple injections of local anesthetic were
given, and perhaps the preoperative application of lidocaine and prilocaine (EMLA)





































































middle ear surgery under local anesthesia is the ability to test hearing during surgery,
and they also report less bleeding. The main concerns of not performing middle ear
surgery under local anesthesia are that patients may not tolerate the discomfort and
the possibility of sudden movement. Another drawback is potential toxicity, as near-
toxic plasma levels of local anesthetic have been reported in the first 5 minutes
following infiltration for tympanoplasty.9 The head may be obscured by drapes during
surgery, and extra vigilance is required for possible respiratory depression or airway
obstruction. Supplementary oxygen can be provided with nasal cannulae, and it is
also possible to use capnometry or a precordial stethoscope to monitor breathing.
Clear plastic drapes may reduce feelings of claustrophobia, and a forced air device
can be used to provide some room air ventilation.
Thus, with careful patient selection, adequate preoperative explanation, and appro-
priate use of sedation, middle ear surgery can be successfully performed under local
anesthesia, with high patient and operator satisfaction and acceptance. Benedik and
Manohin10 compared safety and efficacy of propofol versus midazolam for conscious
sedation in middle ear surgery. The study demonstrated that propofol was associated
with significantly shorter recovery time and better patient and surgeon satisfaction
compared with midazolam. Adverse effects of propofol and midazolam, such as respi-
ratory depression, hypotension, and sudden intraoperative movements, are obvious
drawbacks.
Alpha-2 agonists such as clonidine or, more recently, dexmedetomidine, may have
some advantages, as they produce arousable sedation, analgesia, and a modest
reduction in heart rate and blood pressure without respiratory depression, particularly
important when the head is obscured by surgical drapes.11 Dexmedetomidine has
been used successfully as the primary sedative with supplementary low-dose propo-
fol and midazolam for monitored anesthesia care during awake thyroplasty, a proce-
dure that requires the patient to verbalize when asked and otherwise remain
immobile.12 Surgeons reported satisfactory operating conditions, and patients had
no recall of the procedure and no pain.12 It also has a role in awake craniotomy.13
Thus, dexmedetomidine could be used in a similar way for middle ear surgery but
has not been widely reported in the literature.
In summary, the advantages of performing middle ear surgery under local anes-
thesia and conscious sedation include less bleeding, reduced pain in the immediate
postoperative period, early mobilization, cost-effectiveness, and the ability to test
hearing restoration during surgery.8
Despite these advantages, however, and the special concerns of general anesthesia
for middle ear surgery outlined earlier, most middle ear surgery is still performed under
general anesthesia.
Total intravenous anesthesia (TIVA) versus volatile-based anesthesia for middle
ear surgery long has been a subject of debate. Mukherjee and colleagues14
compared PONV, pain, and conditions for surgery in patients who had undergone
middle ear surgery under TIVA using remifentanil and propofol, with technique using
fentanyl, propofol, and isoflurane maintenance. More patients in the inhalation group
suffered from PONV (25%) versus the TIVA group (8%) in the recovery room. In the
early postoperative period, the TIVA group reported higher pain scores and required
more morphine in the recovery room, but there was no significant difference at 2, 4,
6, 8, 12, and 18 hours. Conditions for surgery in the TIVA group were reported to be
superior. In another study comparing propofol-based anesthesia with inhalation
anesthetic techniques in terms of recovery profile and incidence of PONV for middle
ear surgery, TIVA was associated with more rapid emergence and less nausea and
vomiting.15,16XATC208_proof ■ 20 July 2010 ■ 10:24 pm
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The use of nitrous oxide in anesthetic practice has declined in recent years as
a result of concerns over both physical and metabolic effect.17,18 The use of nitrous
oxide in middle ear surgery is particularly controversial. Nitrous oxide is more soluble
than nitrogen in blood and in high concentrations enters the middle ear cavity more
rapidly than nitrogen leaves, causing a raise in middle ear pressure if the eustachian
tube is obstructed.4,5 During tympanoplasty, the middle ear is open to the atmo-
sphere; thus there is no build-up of pressure, but once a tympanic membrane graft
is placed the continued use of nitrous oxide might cause displacement of graft. At
the end of surgery, when it is discontinued, nitrous oxide is rapidly absorbed, which
may then result in negative pressure also possibly resulting in graft dislodgement,
serous otitis media, disarticulation of the stapes, or impaired hearing.4,5 Thus, the
use of nitrous oxide is not recommended in tympanoplasty. Furthermore, a well known
adverse effect of nitrous oxide is PONV, and consequently, its use in middle ear
surgery may further increase the incidence of PONV above that already associated
with this type surgery.
Endotracheal intubation and laryngoscopy during general anesthesia is associated
with many potential complications such as sore throat, cough, dental injury, difficult
emergence, and use of muscle relaxants for tube insertion.19 In comparison, the
LMA is free from such complications, and a smooth recovery can be attained easily.
It also offers advantages of intravenous sedation with less risk of over sedation and
obstructive apnea.20 Safety and efficacy of the LMA were compared with endotra-
cheal intubation in patients who underwent otologic surgery in a retrospective chart
review study conducted at a military tertiary care teaching hospital. No major airway
complication was reported in either group; a significant decrease in the use of neuro-
muscular blockers was noted in the LMA group, and total anesthetic time was also
shorter in this group. There was no difference in the incidence of PONV or duration
of postanesthesia care unit stay.21 The use of the LMA for head and neck procedures
is reviewed by Mandel in this issue.
A bloodless operative field is essential, because even a few drops of blood can
obscure the surgical field. Physical and pharmacologic techniques are used:
a head-up tilt 15 to 20, avoidance of venous obstruction, normocapnia, and
controlled hypotension. Controlled hypotension is defined as a reduction of systolic
blood pressure to 80 mm Hg90 mmHg, a reduction of mean arterial pressure to
50 mm Hg to 65 mm Hg in patients without hypertension, or a reduction of 30%
of baseline mean arterial pressure in patients with hypertension.22 A slightly elevated
position of the head reduces arterial and venous pressures in areas above the heart;
however, it increases the risk of air embolism. In the presence of hypotension,
elevating the head will further compromise perfusion of the head and neck region.
Pharmacologic agents used for controlled hypotension in ear, nose, and throat
surgery include: inhalation anesthetics (eg, isoflurane and sevoflurane), vasodilators
(eg, sodium nitroprusside and nitroglycerin), beta adrenoceptor antagonists (labetalol
and esmolol), alpha-2 adrenergic agonists (clonidine and dexmedetomidine), opioids
(remifentanil),23 and more recently magnesium sulfate.24 However, controlled hypo-
tension is not without risk; in addition to the adverse effects of certain pharmacologic
agents, it can cause tissue hypoxia by reducing microcirculatory autoregulation of
vital organs.
In moderate concentrations, isoflurane lowers blood pressure via a vasodilating
effect while preserving cerebral autoregulation. However, at higher concentrations,
it causes an increase in intracranial pressure due to increased cerebral blood flow
and impairment of cerebral autoregulation.23 Sevoflurane produces its hypotensive






































































it has a low blood gas solubility and low airway irritability, making it a good agent for
gas induction in pediatric patient, although its use is commonly associated with emer-
gence agitation and negative postoperative behavioral changes in this group.27 In high
concentrations, inhalation anesthetics interfere with the measurement of evoked
potentials use for facial nerve monitoring.
The vasodilators sodium nitroprusside and nitroglycerin have become less popular
because of adverse effects and the availability of better agents. Sodium nitroprusside
is very potent and has a fast onset and offset, but it has several serious adverse effects
including tachyphylaxis, rebound hypertension, organ ischemia, and cyanide
toxicity.23 Sodium nitroprusside employed as an adjunct to sevoflurane anesthesia
in children improved surgical field visibility but provoked lactic acidosis and increased
hypercapnia.23 Nitroglycerin is a short acting nonspecific direct vasodilator of venous
and arterial vessels, which does not produce toxic metabolites. Compared with
sodium nitroprusside, nitroglycerin is less effective in inducing hypotension and
does so more slowly.23 Both agents require close blood pressure monitoring, prefer-
ably with an arterial line.
Labetalol is a competitive antagonist at beta and alpha receptors with a ratio of 7:1.
Beta adrenoceptor blockade decreases myocardial contractility and heart rate, while
alpha blockade produces vasodilatation.23 Adverse effects include bronchospasm,
prolonged hypotension, and conduction blockade. Esmolol is a short-acting beta-1
adrenoceptor antagonist, which has an onset time of about 3 minutes and duration
of action of approximately 10 minutes. It decreases blood pressure by lowering heart
rate and reducing renin activity and catecholamine levels.28 Compared with sodium
nitroprusside, beta adrenoceptor antagonists lower blood pressure and reduce blood
flow to the middle ear and improve surgical field without metabolic complications.22
The alpha-2 adrenoceptor agonists, clonidine and dexmedetomidine, have been
discussed earlier in relation to their sedative and analgesic properties. They also mark-
edly reduce catecholamine secretion, are anesthetic sparing, and produce moderate
bradycardia and hypotension.27,29,30 A randomized study investigating the effective-
ness of dexmedetomidine in reducing bleeding during septoplasty and tympanoplasty
operations demonstrated dexmedetomidine significantly reduced bleeding and fen-
tanyl requirement in septoplasty and reduced fentanyl requirement in tympanoplasty
operations, but the decrease in bleeding was not significant.30 Durmus and
colleagues31 used dexmedetomidine to improve the quality of surgical field in both
tympanoplasty and septoplasty, and concluded that dexmedetomidine is a useful
adjuvant to decrease bleeding.
Remifentanil is an ultrashort-acting mu receptor agonist. It is able to decrease
systemic blood pressure, reduce blood flow to the middle ear, and produce better visi-
bility in the operative field without impairing autoregulation of the middle ear microcir-
culation.23,32 The proposed mechanism of action is via central sympathetic blockade.
Degoute and colleagues32 reported that remifentanil combined with sevoflurane in
children enabled controlled hypotension, reduced middle ear blood flow, and
provided a good surgical field for middle ear surgery with no additional need for other
hypotensive agents. Furthermore, remifentanil reduced sevoflurane requirement and
helped avoid the use of muscle relaxants. There is some evidence that intraoperative
infusion of high doses of remifentanil can cause postoperative hyperalgesia,
increasing the postoperative analgesic requirement but this is controversial.33,34
Magnesium sulfate is a noncompetitive N-methyl-D aspartate (NMDA) receptor
antagonist with antinociceptive effects, and it inhibits entry of calcium ions into cells.
Magnesium sulfate is used as a vasodilator for controlled hypotension. Ryu and








































































in terms of hemodynamic effects and postoperative pain when combined with sevo-
flurane. They reported no significant difference over time in mean arterial pressure
or heart rate between the drugs. Patients in the magnesium sulfate group had a lower
sevoflurane requirement than those receiving remifentanil. Overall, magnesium sulfate
was associated with more stable perioperative hemodynamics and produced better
analgesia and less PONV compared with remifentanil.
Otologic surgical procedures are associated with facial nerve paralysis, and thus
facial nerve protection is an important consideration. Preservation of the facial nerve
can be easily confirmed if the patient is not paralyzed,4 but use of muscle relaxants
compromises the interpretation of evoked facial electromyographic activity. Since
any sudden movement could jeopardize surgery, it has been suggested that partial
neuromuscular blockade as determined by train-of-four peripheral nerve stimulation
be used.35
Middle ear surgery is associated with a high incidence of PONV. In the absence of
antiemetic treatment, 62% to 80% of patients will be afflicted.36 The etiology of PONV
is multifactorial and depends on various factors, including patient demographics,
history of PONV, anesthetic technique, use of nitrous oxide, duration of anesthesia
and operation, and even surgical experience.37–39 TIVA reduces PONV compared
with using volatile agents.14 Use of nitrous oxide is associated with a higher incidence
of PONV. Patients operated on by residents required more aggressive prophylaxis for
PONV than those operated on by specialists.39 Prophylactic administration of anti-
emetic medication also decreases the incidence of PONV. Usmani and colleagues37
compared the efficacy of ondansetron (0.1 mg/kg), dexamethasone (0.15 mg/kg)
and a combination of ondansetron (0.1 mg/kg) and dexamethasone (0.15 mg/kg) for
prevention of PONV in a randomized double-blind study involving 90 ASA I and II
patients. They concluded that prophylactic therapy with ondansetron together with
dexamethasone is superior to either drug alone. Another study comparing the efficacy
of combining granisetron and dexamethasone to either drug alone yielded similar
results.40 This also holds true in pediatric patients.41,42 Thus, the combination of
a selective 5-hydroxy tryptamine type 3 receptor antagonist together with dexameth-
asone is more effective in preventing PONV than either drug alone. Yeo and
colleagues43 compared the antiemetic efficacy of dexamethasone combined with
midazolam and concluded that the addition of midazolam did not significantly reduce
the overall incidence of PONV compared with dexamethasone alone. However, the
addition of midazolam did lower the incidence of vomiting and the need for rescue
antiemetic.43
Patients who underwent middle ear surgery under local anesthesia experienced less
immediate postoperative pain than those under general anesthesia. A multimodal
analgesic approach combining opioids, nonsteroidal anti-inflammatory drugs/coxibs,
and acetaminophen is generally appropriate. A recent study found blockade of the
auricular branch of the vagus nerve with 0.2 mL of 0.25% bupivacaine to be more
effective than intranasal fentanyl (2 mg/kg) in management of postoperative pain in
infants and children undergoing myringotomy and tube placement.44
In conclusion, with careful patient selection, local anesthesia with sedation is
a good alternative to general anesthesia for simple middle ear surgery. General
anesthesia with TIVA provides a better recovery profile and less nausea and vomit-
ing compared with inhalational anesthesia, and nitrous oxide should be avoided.
Remifentanil is a good drug for controlled hypotension and for avoidance of muscle
relaxants. If required, partial neuromuscular blockade can still allow facial nerve
monitoring during surgery. Combination PONV prophylaxis is more effective than
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